I know this trial was for HCC and not CC but I think that Afinitor has been mentioned here a few times here so thought I would post this news piece here just in case anyone is interested in it.
Novartis drug shows no survival benefit in liver cancer.
http://www.reuters.com/article/2013/08/07/us-novartis-afinitor-idUSBRE97607M20130807
http://www.pmlive.com/pharma_news/novartis_says_afinitor_fails_liver_cancer_trial_495455
They are still running phase 3 trials for this with GI cancers with results expected in 2014 – 2015.
Gavin